Literature DB >> 19158276

Chromatin-specific remodeling by HMGB1 and linker histone H1 silences proinflammatory genes during endotoxin tolerance.

Mohamed El Gazzar1, Barbara K Yoza, Xiaoping Chen, Benjamin A Garcia, Nicolas L Young, Charles E McCall.   

Abstract

Epigenetic silencing of tumor necrosis factor alpha (TNF-alpha) and interleukin 1beta (IL-1beta) transcription occurs in blood leukocytes of animals and humans after the initiation of severe systemic inflammation (SSI). We previously reported that the epigenetic signature requires induction of NF-kappaB factor RelB, which directs histone H3K9 dimethylation, disrupts assembly of transcription activator NF-kappaB p65, and induces a sustained switch from the euchromatin to heterochromatin. Here, we report the novel findings that intracellular high mobility group box 1 protein (HMGB1) and nucleosome linker histone H1 protein are necessary components of endotoxin-mediated silencing of TNF-alpha in THP-1 human promonocytes. HMGB1 binds the TNF-alpha promoter during transcription silencing and promotes assembly of the repressor RelB. Depletion of HMGB1 by small interfering RNA results in dissociation of RelB from the promoter and partially restores TNF-alpha transcription. Histone H1, which typically displaces HMGB1 from nucleosomal DNA, also binds concomitantly with HMGB1 to the heterochromatin of the silenced TNF-alpha promoter. Combined knockdown of HMGB1 and H1 restores binding of the transcriptionally active NF-kappaB p65 and reestablishes TNF-alpha mRNA levels. Chromatin reimmunoprecipitation experiments demonstrate that HMGB1 and H1 are likely recruited to TNF-alpha sequences independently and that their binding correlates with histone H3K9 dimethylation, as inhibition of histone methylation blocks HMGB1 and H1 binding. Moreover, HMGB1- and H1-mediated chromatin modifications are gene specific during endotoxin silencing in that they also bind and repress acute proinflammatory IL-1beta, while no binding nor repression of antiinflammatory IkappaBalpha is observed. Finally, we find that H1 and HMGB1 bind to the TNF-alpha a promoter in human leukocytes obtained from patients with SSI. We conclude proinflammatory HMGB1 and structural nucleosome linker H1 couple as a component of the epigenetic complex that silences acute proinflammatory TNF-alpha during the assembly of heterochromatin in the SSI phenotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19158276      PMCID: PMC2655606          DOI: 10.1128/MCB.01862-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

Review 1.  New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal.

Authors:  S Müller; P Scaffidi; B Degryse; T Bonaldi; L Ronfani; A Agresti; M Beltrame; M E Bianchi
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

Review 2.  Chromatin condensation: does histone H1 dephosphorylation play a role?

Authors:  S Y Roth; C D Allis
Journal:  Trends Biochem Sci       Date:  1992-03       Impact factor: 13.807

3.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.

Authors:  Tiziana Bonaldi; Fabio Talamo; Paola Scaffidi; Denise Ferrera; Annalisa Porto; Angela Bachi; Anna Rubartelli; Alessandra Agresti; Marco E Bianchi
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

4.  Acidic C-tail of HMGB1 is required for its target binding to nucleosome linker DNA and transcription stimulation.

Authors:  Tetsuya Ueda; Hiroyasu Chou; Toshifumi Kawase; Hitoshi Shirakawa; Michiteru Yoshida
Journal:  Biochemistry       Date:  2004-08-03       Impact factor: 3.162

5.  Human tumor necrosis factor alpha gene regulation by virus and lipopolysaccharide.

Authors:  A E Goldfeld; C Doyle; T Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

6.  High mobility group protein-1 (HMG-1) is a unique activator of p53.

Authors:  L Jayaraman; N C Moorthy; K G Murthy; J L Manley; M Bustin; C Prives
Journal:  Genes Dev       Date:  1998-02-15       Impact factor: 11.361

7.  Epigenetic silencing of tumor necrosis factor alpha during endotoxin tolerance.

Authors:  Mohamed El Gazzar; Barbara K Yoza; Jean Y-Q Hu; Sue L Cousart; Charles E McCall
Journal:  J Biol Chem       Date:  2007-07-23       Impact factor: 5.157

8.  Reversing established sepsis with antagonists of endogenous high-mobility group box 1.

Authors:  Huan Yang; Mahendar Ochani; Jianhua Li; Xiaoling Qiang; Mahira Tanovic; Helena E Harris; Srinivas M Susarla; Luis Ulloa; Hong Wang; Robert DiRaimo; Christopher J Czura; Haichao Wang; Jesse Roth; H Shaw Warren; Mitchell P Fink; Matthew J Fenton; Ulf Andersson; Kevin J Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-26       Impact factor: 11.205

9.  High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.

Authors:  U Andersson; H Wang; K Palmblad; A C Aveberger; O Bloom; H Erlandsson-Harris; A Janson; R Kokkola; M Zhang; H Yang; K J Tracey
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

10.  A labile transcriptional repressor modulates endotoxin tolerance.

Authors:  K E LaRue; C E McCall
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  75 in total

Review 1.  Macrophage polarization and plasticity in health and disease.

Authors:  Subhra K Biswas; Manesh Chittezhath; Irina N Shalova; Jyue-Yuan Lim
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 2.  Gene-specific epigenetic regulation in serious infections with systemic inflammation.

Authors:  Charles E McCall; Barbara Yoza; Tiefu Liu; Mohamed El Gazzar
Journal:  J Innate Immun       Date:  2010-04-27       Impact factor: 7.349

Review 3.  Epigenetic regulation of immune cell functions during post-septic immunosuppression.

Authors:  William F Carson; Karen A Cavassani; Yali Dou; Steven L Kunkel
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

4.  Facultative heterochromatin formation at the IL-1 beta promoter in LPS tolerance and sepsis.

Authors:  Barbara K Yoza; Charles E McCall
Journal:  Cytokine       Date:  2011-02       Impact factor: 3.861

5.  AAL exacerbates pro-inflammatory response in macrophages by regulating Mincle/Syk/Card9 signaling along with the Nlrp3 inflammasome assembly.

Authors:  Zhijun Zhang; Long He; Shuang Hu; Yi Wang; Qiaohong Lai; Ping Yang; Qilin Yu; Shu Zhang; Fei Xiong; Sakine Simsekyilmaz; Qin Ning; Jinxiu Li; Dongshan Zhang; Hongliang Zhang; Xudong Xiang; Zhiguang Zhou; Hui Sun; Cong-Yi Wang
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

6.  Quantitative proteomics reveals a role for epigenetic reprogramming during human monocyte differentiation.

Authors:  Dequina Nicholas; Hui Tang; Qiongyi Zhang; Jai Rudra; Feng Xu; William Langridge; Kangling Zhang
Journal:  Mol Cell Proteomics       Date:  2014-10-14       Impact factor: 5.911

Review 7.  Role of H1 linker histones in mammalian development and stem cell differentiation.

Authors:  Chenyi Pan; Yuhong Fan
Journal:  Biochim Biophys Acta       Date:  2015-12-13

8.  IFN-γ abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling.

Authors:  Janice Chen; Lionel B Ivashkiv
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

Review 9.  The immunopathology of sepsis and potential therapeutic targets.

Authors:  Tom van der Poll; Frank L van de Veerdonk; Brendon P Scicluna; Mihai G Netea
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

10.  In vivo analysis of γH2AX+ cells in skeletal muscle from aged and obese humans.

Authors:  Cory M Dungan; Bailey D Peck; R Grace Walton; Zhengyan Huang; Marcas M Bamman; Philip A Kern; Charlotte A Peterson
Journal:  FASEB J       Date:  2020-04-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.